Regeneron sees $388 million third quarter income

Regeneron posted a GAAP net income of $388 million, or $3.64 per share, for the third quarter of 2017, compared with a net income of $265 million, or $2.53 per share, in the same quarter of 2016.
Total revenues were reported at $1.501 billion, compared with $1.22 billion in the previous year’s third quarter. Eylea (aflibercept) sales increased from $854 million to $953 million in the United States, while net product sales rose from $857 million to $957 million.
General and administrative costs were $307 million vs. $270 million in (Read more...)

Full Story →